⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNSY News
Cerenome, Inc. Common Stock
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
globenewswire.com
CNSY
Cerenome Launches CNSide® CSF Molecular Profile Tests
globenewswire.com
CNSY
Form 8-K
sec.gov
CNSY
Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
globenewswire.com
CNSY
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
globenewswire.com
CNSY
Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
globenewswire.com
CNSY
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
globenewswire.com
CNSY
Form 8-K
sec.gov
CNSY
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
globenewswire.com
CNSY
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines
globenewswire.com
CNSY